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Background: Onchocerciasis is caused by Onchocerca volvulus and transmitted by Simulium species (black flies). In
the Americas, the infection has been previously described in 13 discrete regional foci distributed among six
countries (Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela) where more than 370,000 people are
currently considered at risk. Since 2001, disease control in Venezuela has relied on the mass drug administration to
the at-risk communities. This report provides empirical evidence of interruption of Onchocerca volvulus transmission
by Simulium metallicum in 510 endemic communities from two Northern foci of Venezuela, after 10–12 years of
6-monthly Mectizan® (ivermectin) treatment to all the eligible residents.
Methods: In-depth entomologic and epidemiologic surveys were serially conducted from 2001–2012 in selected
(sentinel and extra-sentinel) communities from the North-central (NC) and North-east (NE) onchocerciasis foci of
Venezuela in order to monitor the impact of ivermectin treatment.
Results: From 2007–2009, entomological indicators in both foci confirmed that 0 out of 112,637 S. metallicum
females examined by PCR contained L3 infection in insect heads. The upper bound of the 95% confidence intervals
of the infective rate of the vector reached values below 1% by 2009 (NC) and 2012 (NE). Additionally, after 14 (NC)
and 22 (NE) rounds of treatment, the seasonal transmission potential (±UL CIs) of S. metallicum was under the
critical threshold of 20 L3 per person per season. Serological analysis in school children < 15 years-old
demonstrated that 0 out of 6,590 individuals were harboring antibodies to Ov-16. Finally, epidemiological surveys
made during 2010 (NC) and 2012 (NE) showed no evidence of microfilariae in the skin and eyes of the population.
Conclusions: These results meet the WHO criteria for absence of parasite transmission and disease morbidity in
these endemic areas which represent 91% of the population previously at-risk in the country. Consequently, the
two Northern foci are currently under post-treatment onchocerciasis surveillance status in Venezuela.
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Onchocerciasis is a chronic infection caused by the filarial
worm Onchocerca volvulus (Leuckart) and transmitted
exclusively to humans through the bites of black fly species
of the genus Simulium Latreille. Parasite impact on human
health is through the clinical repercussions of the infection
of the skin and eyes. Onchocerca volvulus embryonic forms
(microfilariae [mf]) migrate through the skin and cause
severe itching, disfiguring disease, and ocular lesions. Visual* Correspondence: mariaeugenia.grillet@gmail.com
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reproduction in any medium, provided the orloss and blindness can be the result of heavy parasite loads
in the human host over time.
In the Americas, thirteen onchocerciasis foci have been
described in Brazil, Colombia, Ecuador, Guatemala, Mexico
and Venezuela, where about 379,234 persons were consid-
ered at risk of infection as of 2013 [1]. In this region, several
ecological settings are associated with distinct but well-
adapted Onchocerca–Simulium complexes which show
various parasite transmission intensities, degrees of infec-
tion severity, clinical manifestations, and epidemiological
patterns. In Venezuela, the epidemiology of onchocerciasis
is heterogeneous with two contrasting endemic regions.
There is a northern endemic area localized in the coastalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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disease foci that are geographically separated but similar in
their epidemiology, namely the North-central [2] and
North-east [3] foci. Here, about 108,968 persons from the
rural population are at risk [4] and infection is transmitted
by Simulium metallicum sensu lato Bellardis [5-7]. In con-
trast, the southern onchocerciasis Amazonian focus is con-
fined to the rainforest of the Upper Orinoco River region,
affecting about 10,390 people [4] from the indigenous
Yanomami population [8,9]. In this second endemic area, S.
guianense s.l. Wise, S. incrustatum Lutz, and S. oyapockense
s.l. Floch and Abonnenc are the vectors [10-12].
The main approach taken in the Americas to battle
onchocerciasis has been to eliminate the parasite by
using mass drug administration, MDA [13,14]. Specific-
ally, the Onchocerciasis Elimination Program for the
Americas (OEPA), a regional partnership program
founded in 1992, has relied on the mass administration
of ivermectin (Mectizan®, Merck & Co Inc) in order to
eliminate new ocular morbidity produced by O. volvulus
and interrupt transmission of the parasite by the year
2015 [1,13]. Ivermectin is a drug that kills the mf in the
skin and temporarily inhibits their release by gravid
adult worms [15] as well as killing adult worms after
several years of mass treatment given at 6-monthly inter-
vals [14,16]. In the Americas, a key and successful strat-
egy has been to employ regular semi-annual and, lately,
tri-monthly treatment rounds with coverage (proportion
of the population treated) higher than 85% of the eligible
population [1,13,17,18]. Indeed, the onchocerciasis elim-
ination program in Venezuela, as those in the other 5
endemic Latin American countries, has relied on this
health strategy since 2001.
The present work reports for the first time in Venezuela
the interruption of O. volvulus transmission in 510 endemic
communities localized in the Northern area of the country
after 10–12 continuous years of ivermectin treatment. In
the Americas, baseline and further clinical, parasitological,
ophthalmological and entomological evaluations carried
out in selected communities within each regional focus
every 4 years have allowed us to monitor the impact of
Mectizan® administration on the transmission of O. volvulus.
We present here the results obtained from several in-
depth epidemiological and entomological follow-up studies
carried out in the two northern foci from 2001 onwards.
This success now allows us to state onchocerciasis trans-




The onchocerciasis North-central focus [2] encompasses
6 administrative States (Figure 1) and 45 endemic com-
munities. The population at-risk (14,835 individuals)corresponds to about 12% of the total at-risk population
in the country. The North-east focus [3], by contrast,
includes 3 administrative States (Figure 1) but 465
endemic communities of about 94,583 inhabitants corre-
sponding to 79% of the total at-risk population in the
country. The residents of both endemic areas are mainly
part of the rural population dedicated to agricultural
activities [7] and the parasite is transmitted by the pre-
dominant human-biting black fly Simulium metallicum
s.l. [5-7]. In this geographical area, the annual mean
temperature is about 24°C - 27°C and the total annual
rainfall is 1100 mm, with a rainy season from May to
October and a dry season from November to April [7].
The main onchocerciasis transmission season occurs at
the end of the rainy season and beginning of dry season
[21].
Survey communities: sentinel and extra-sentinel
communities
From 1997 to 1999, the Venezuelan National program, co-
ordinated by the local health authorities (Regional Derma-
tology Services) and the Biomedicine Institute compiled the
complete epidemiological history and endemic status of the
disease in the northern area according to previously pub-
lished reports from the Venezuelan Minister of Health. This
pre-ivermectin information allowed the basal epidemio-
logical stratification of all the communities in both foci
(North-central and North-east).
In the North-central focus (NC), a total of 45 communi-
ties were classified - 42 hypoendemic (prevalence of mf
infection < 20%), two mesoendemic (prevalence ≥ 20% but
lower than 60%) and one hyperendemic (prevalence ≥
60%). Here, ocular pathology (about 37.9% and 31%
prevalence of microfilariae in the cornea [MFC] and the
anterior chamber of the eye [MFAC], respectively) was the
major clinical manifestation attributable to onchocerciasis
according to previous records. By contrast, skin disease
(about 1.2 community microfilariae load [CMFL]) and
pruritus were minor manifestations, whereas parasite nod-
ules and blindness were absent. From the 45 communities,
a total of 1 sentinel and several extra-sentinel communities
were selected as those communities where regular in-depth
epidemiological evaluations (EEPs) would be conducted in
order to monitor the impact of treatment on parasite trans-
mission (Figure 1). Santa Rosa del Sur (825 m.a.s.l.), having
a current population of 129 inhabitants, was chosen as the
sentinel community (70% of mf basal prevalence). La
Llanada (713 m; 119 inhabitants; 48.2% of basal preva-
lence), Virgen Pura (849 m; 115 inhabitants; 23.8% of basal
prevalence) and El Chino (854 m; 137 inhabitants; 12.5% of
basal prevalence) were selected as the extra-sentinel com-
munities. A fourth extra-sentinel hypo-endemic community
was used (BuenaVista: 547 m; 174 inhabitants) for entomo-
logical evaluations in order to increase the statistical
Figure 1 Map of Venezuela. Map of Venezuela (including topographic layer) showing the nine administrative boundaries (States) where the
onchocerciasis has been endemic in the northern region of the country. Red areas over the map represent the two endemic foci extent. Red
points over the enlarged States correspond to those communities (sentinel and extra-sentinel) were regular in-depth epidemiological evaluations
(EEPs) were conducted in order to monitor the impact of treatment on parasite transmission in both foci.
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of parasite transmission.
In the North-east focus, a total of 233 hypoendemic, 197
mesoendemic and 35 hyperendemic communities were
identified prior to the beginning of ivermectin treatment.
Here, the basal ocular pathology was ≈ 27.8% (MFC) and
25.3% (MFAC), whereas skin disease (CMFL ~ 0.58) and
pruritus were minor manifestations. Parasite nodules and
blindness were absent. From the 465 communities, a total
of 5 sentinels and 8 extra-sentinels communities were se-
lected (Figure 1). La Carapa (697 m; 202 inhabitants; 73.3%
of basal prevalence), Voladero (628 m; 202 inhabitants; 60%
of basal prevalence), Santa Marta (118 m; 184 inhabitants;
62.5% of basal prevalence), Caituco (98 inhabitants; 72.7%
of basal prevalence), and La Cuesta (261 m; 218 inhabi-
tants; 68.8% of basal prevalence) were the sentinel commu-
nities. The extra-sentinel communities were: Manapire
Abajo (508 m; 315 inhabitants; 76.7% of basal prevalence),
Guayabal (468 m; 206 inhabitants; 65.5% of basalprevalence), El Filudo (570 m; 99 inhabitants; 28% of basal
prevalence), El Naranjal (436 m; 86 inhabitants; 75% of
basal prevalence), El Piñal (71.4% of basal prevalence),
Sabaneta (422 m; 160 inhabitants; 87.5% of basal preva-
lence), Jenjibral (414 m; 36 inhabitants; 44.4% of basal
prevalence), and Apamatal (453 m; 30 inhabitants; 55.6% of
basal prevalence).
In-depth epidemiological evaluations carried out from
2001 onwards allowed us to update the endemic status of
both foci. Most of the above communities showed lower
disease prevalence than previously reported, with most of
the communities lying in hypoendemic and mesoendemic
disease levels. The onchocerciasis elimination program in
Venezuela (OEPV) started during 2001 the 6 monthly regu-
lar mass treatments with Mectizan® to every eligible resi-
dent in all the affected communities from the Northern
area of Venezuela (Figure 2). The 85% goal of coverage
treatment was reached two (North-central) and three
(North-east) years later and that level remained until 2010
Figure 2 Coverage rate with ivermectin, northern Venezuela. Coverage rate (percent) with ivermectin of the eligible population of the
North-central (a) and North-east (b) foci, Venezuela, 2001–2012. The line at 85% indicates the coverage needed in a sustained way to
interrupt transmission.
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reached 20 (North-central) and 24 (North-east) regular
treatment rounds, respectively.
WHO criteria to onchocerciasis elimination
In 2001 WHO published the document “Certification of
elimination of human onchocerciasis: criteria and proce-
dures,” which established the different phases to be
followed by a country to achieve certification of elimin-
ation of onchocerciasis [19]. Each phase is associated
with an aspect of parasite transmission resulting in four
phases. More recently, OEPA, through its program co-
ordinating committee (PCC), published a field document
that has as its focus the 3-year period defined by
post-treatment surveillance (PTS) and describes the
activities that distinguish and bridge phase transmission
interrupted and phase transmission eliminated [20].
Thus, the following phases have been recognized andpursued by each country in the Americas to achieve the
goal of parasite and disease elimination [19,20]. Stage 1
is the phase of ongoing transmission characterized by the
presence of O. volvulus infective larvae (L3 stage) in the
vector population (insect heads) and parasite mf in skin,
parasite nodules and serology in the population and es-
pecially in children < 5 year-old. Stage 2 is when most of
the above transmission indicators start to show negative
results, consequently, the status of the focus changes to
suppressed transmission. In Stage 3, transmission is
regarded as interrupted when the focus (in overall) has
reached specific epidemiological indicators such as: i)
prevalence of < 1% of O. volvulus mf in the cornea and/
or anterior chamber of the eye, ii) an infectivity rate (L3
infection in heads) by PCR of < 1/1000 (0.1%) in parous
flies or <1/2000 (0.05%) in all flies, assuming a 50% par-
ous rate, iii) an annual transmission potential (ATP) or
seasonal transmission potential (STP) under 20 L3s per
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incidence rate of less than one new case per 1,000 indi-
viduals (<0.1%) defined as lack of specific Ov-16 anti-
bodies to O. volvulus in school children. In this phase,
suspension of treatment is recommended and a 3-year
period post-treatment surveillance is initiated in the
focus. Stage 4 occurs after the 3 years of post-treatment
surveillance, when the surveillance parameters have been
carried out and all results confirm no recrudescence
of disease. Consequently, onchocerciasis is declared
eliminated by WHO after the country requests evaluation
[19,20]. Requests for certification of elimination are not
made by focus, but by country. However, the report by
focus of the empirical evidences about the local interrup-
tion (Stage 3) and/or elimination (Stage 4) of disease
transmission will contribute, progressively, to support the
final request for certification of each country.
Entomologic indicators
Based on the previous guidelines, in the sentinel and
extra-sentinel communities, and during several (e.g.,
three to five) consecutive collection days, host-seeking S.
metallicum females were collected throughout the trans-
mission season (September to March) by using standard-
ized procedures [11,20]. In the North-central focus,
entomological collections were performed from Septem-
ber 2007 to March 2008 in the sentinel community, and
from September to November 2009 in the extra-sentinel
communities. For the North-east focus, black fly collec-
tions were performed from September 2007 to March
2008, and during 2011 in the 5 sentinel communities.
Similar entomological catches were carried out during
2010 (September to November) and 2012 (September to
November) in 5 extra-sentinel communities. All the
simuliid females that landed on two human attractants
from each community were caught with manual aspira-
tors by a team of two collectors and two attractants dur-
ing the first 50 minutes of each hour, beginning at 09:00
hours and ending at 17:50 hours, with one stop hour
(12:00 – 13:00). This period coincided with the highest
number of parous females of S. metallicum (unpublished
results). This amounted to 8 collection periods per
catching day. Females were collected before procuring
a blood meal. Attractants received Mectizan® 1 week
before beginning the collection process. Whenever pos-
sible, the collection team was the same throughout the
surveys to minimize variations resulting from individual
differences in catching ability. In the field, all hourly-
caught flies were anesthetized with chloroform vapour,
identified to species, and counted by the hour, day,
date, and community. The number of collection days
depended on the biting density for each community and
followed criteria to calculate a more precise transmission
potential (TP) index (see below). Polymerase chainreaction (PCR) using O. volvulus -specific DNA probes
(see below) is generally applied to examine pools of flies
in the OEPA region [19,20]. Therefore, by each commu-
nity, flies were combined into pools containing a max-
imum of 50 individuals per pool and the heads and
bodies tested separated for O. volvulus by using a PCR
assay specific for this parasite species [22]. Details of
protocols for genomic DNA purification and parasite
detection have been published elsewhere [22,23]. Body
pools were analyzed first; if any of the body pools were
positive, the body testing was repeated. If the positive
body pool was confirmed then body pool testing was
suspended and all of the head pools were then analyzed.
Positives were confirmed by a second PCR as part of a
process to standardize this procedure from the Univer-
sity of South Florida [20]. Since the female parity status
(proportion of females that have already laid a batch of
eggs) is usually hard to determine in black fly catches in
the field, the OEPA entomological criterion for interrup-
tion of transmission or transmission threshold is less
than one infective fly per 2,000 flies tested (assuming
50% of these are parous flies). To reach this standard, it
has been determined that the minimum sample size re-
quired to exclude a prevalence of infective flies of 0.05%
in all flies at a 95% CI, given that no infective fly is
found, is roughly 6,000 flies by focus [20]. In addition to
these criteria, during 2006, an OEPA-convened meeting
of entomologists recommended the use of ATP or STP
to further assess the status of onchocerciasis transmis-
sion in the Americas, because both of these measure-
ments take into account the biting rate and the
prevalence of infective flies [20,24]. All entomologists at
that meeting agreed that an ATP < 20 L3s/person/year
represented interruption of parasite transmission, based
on previous theoretical [25] and field [26] estimates
carried out in the region.
Regarding the northern endemic area of Venezuela,
pre-treatment entomological surveys carried out during
1998–1999 in some of the sentinel communities found
that the S. metallicum infectivity rates (proportion of
flies with infective-stage O. volvulus larvae per 2000 flies
examined) varied from 0.0003 (95% CIs: 0.0001-0.006) to
0.0009 (95% CIs: 0.0005-0.0014) in the North-east focus;
whereas the infectivity rate showed values of 0.0005
(95% CIs: 0.0003-0.0008) in the only sentinel locality of
the North-central focus [27].
Serologic indicators
Here, the objective was to measure the prevalence of
IgG4 antibodies to Ov-16, a recombinant pre-patent
antigen of O. volvulus [28-30]. The OV-16 testing in
ELISA is currently being used in sero-surveys in areas
where transmission is thought to be interrupted in the
Americas region [20]. For that, three serological surveys
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years old) from the 45 endemic communities of the
North-central focus during 2008, 2009 and 2010. Like-
wise, three serological surveys (children < 5 years old)
were performed during 2006, 2009 and 2012 from the
465 endemic communities of the North-east focus. The
sample size required to calculate a one-sided 95% confi-
dence interval (CI) for a point prevalence that excludes
0.1% has been determined to be around 3,000 children
or all the children of eligible age in the endemic area.
The serological protocol was as follows [30]. Sterile pro-
cedures were used to prick the fingers of all participants
and four to six drops of blood (80–120 μL) were
absorbed onto Whatman No 2 filter paper. The filter
paper blood samples were dried, separated by sheets of
paper, and then bundled and stored in sealed plastic bags
in a cooler until they were returned to the laboratory
where they were stored at −20°C. Two 6 mm punches of
blood-saturated filter paper were placed in a phosphate-
buffered saline (Tween 0.05% and bovine serum albumin
5%) and eluted overnight at 4°C. The elution was then
run in duplicate in a standard ELISA to detect IgG4
antibodies against the Ov-16 recombinant antigen [30].Parasitological and ophthalmologic indicators
In the North-central focus, a total of 4 parasitological
(2001, 2005, 2008, 2010) and 2 ophthalmologic (2008,
2010) surveys were carried out in the sentinel and extra-
sentinel communities. Alternatively, 4 parasitological
(2001, 2006, 2009, 2012) and 4 ophthalmologic (2001,
2006, 2009, 2012) surveys were performed in the
North-east focus.
The skin snip biopsy was the standard method to
determine the prevalence of microfilariae in the skin as
well as intensity of O. volvulus infection in the studied
population. Two simultaneous skin biopsies were taken
from each patient > 1 year-old from each community by
using a Holth sclerocorneal punch, one from the left
supra-scapular region and the right supra-iliac region,
followed by incubation of the snips for 24 h in buffered
saline solution and counting of the emerging microfilar-
iae under a microscope. The prevalence of microfilariae
in the cornea (MFC) and/or anterior chamber of the eye
(MFAC) was determined by an ophthalmologist experi-
enced in onchocerciasis ocular evaluations.Ethical approval
The entomologic and serologic studies received the ethical
approval of the Ethic Committee of the Biomedicine Insti-
tute (Venezuelan Ministry of Health). All the participants
signed an informed consent form before undergoing any
examination or testing.Data analysis
The infectivity rate in the community and the associated
95% CIs were expressed as the number of positive flies
per 2,000 flies examined [22]. The geometric mean num-
ber of vectors caught per hour is calculated as [exp
(
P
log (χ+1) / η) -1] / 0.833, where χ + 1 is the number
of flies caught in a 50-minute collection period plus 1
(to avoid log [0]), η is the number of collections periods,
and 0.833 is the conversion factor to convert a 50-
minute collection period into 1 hour [20]. This geomet-
ric mean hourly landing rate (which approximates to the
biting rate) was calculated for the vector over the cap-
ture period. The total biting density for the collection
period (called the seasonal biting density, SBD) was cal-
culated as the geometric mean hourly biting rate multi-
plied by 10 potential hours of biting per day and the
number of days in the season. Seasonal transmission po-
tentials (STP) for each sentinel and extra-sentinel village
was calculated as the product of the SBD, the proportion
of flies with infective-stage O. volvulus larvae, and the
mean number of infective larvae per infective fly (as-
sumed to be one in an area of low transmission). This
entomological indicator can be defined as the number of
L3s that a person would potentially receive if the individ-
ual were maximally exposed to black fly bites during
the whole transmission season [31]. The PoolScreen®
software program (Version 2.0; University of Alabama,
Birmingham, AL) was used to estimate the infectivity
rate in the community, that is, the proportion of positive
head pools in the PCR assay. This software employs a
statistical model to calculate the probability of infection
of an individual black fly from the number of positive
pools and the size of the pools is used to calculate the
proportion of infective flies with 95% CI computed using
the Bayesian method [22,32].
Results
North-central focus
Results of the entomological evaluations carried out
from 2007 to 2009 are presented in Table 1, from which
it can be seen that a total of 24,038 S. metallicum
females were collected in sentinel and extra-sentinel
communities (Table 1). Simulium metallicum reached a
SBR of 99,278 bites/person-season in Santa Rosa del Sur,
whilst it was biting at a much lower rate (95%-UL:
24,184 bites/person-season) in the other communities.
All the collected flies were examined by PCR in 248 and
269 pools, respectively. Black fly body pools were nega-
tive for O. volvulus DNA; therefore, insect head pools
were not screened. Upper confidence interval limits of
the prevalence of infective flies in all the communities
were under the critical threshold of 1/2,000 (Table 1).
Upper limits of the STPs in all the communities ranged
from 2.9 to 19.9 L3 per person per season. Table 2 shows
Table 1 Seasonal biting density (SBD), prevalence of infective flies, and seasonal transmission potential (STP) of
S. metallicum (2007–2009) in the sentinel and extra-sentinels communities of the North-central onchocerciasis focus,
Venezuela








Santa Rosa del Sur
(Sentinel)




12,668 19,554 0 (0–0.3) 0 (0–2.9)
(15,771 – 24,184)
*Collection period (season): Sentinel (September 2007-March 2008) and other (November to December 2009) communities.
ψThe associated 95% Confidence Intervals (CIs) surrounding the point estimate.
γSBD: Mean number (geometric mean) of S. metallicum bites per person per season.
δNumber of positive (heads) for O. volvulus L3 per 2,000 flies examined.
θSTP: SBD x prevalence of infective flies x mean number of L3 per infective fly.
σLa llanada, El Chino and Buena Vista.
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no Ov-16 IgG4 antibodies were occurring in the 2,089
children < 15 years old examined in the studied commu-
nities after 8–10 years post-MDA. Finally, the results of
the epidemiological surveys are shown in Table 3. The
prevalence of O. volvulus mf in the sentinel community
depicted a significant decline from a prevalence of 2% of
mf in skin and a geometric mean of 0.1 mf per skin snip
in the community (CMFL) during 2001 to zero levels
from 2005 onwards. These figures have maintained that
level until 2010 where the focus had reached 20 treat-
ment rounds (Figure 2a). No MFC or MFAC were found
among the inhabitants during 2010 (Table 3).
North-east focus
A total of 88,599 S. metallicum females were collected in
this focus (Tables 4 and 5) from 2007 to 2012. The biting
rate of this species ranged from 55,884 bites/person/
season in the community of Caituco to 2,907 bites/person/
season in the Voladero community (Table 4). A total of
700 bodies and 2,089 heads pools of S. metallicum were
examined by PCR, showing a prevalence of 0.06 (43 posi-
tive bodies/700) infected flies by 2,000 and 0 (0 positive
heads/2089) infective flies by 2,000 during the wholeTable 2 Prevalence of IgG4 antibodies to Ov-16 in
children (< 15 years old) from the 45 endemic
communities of the 6 administrative States of the North-
central focus of onchocerciasis, Venezuela
State IgG4 prevalence (positive / no.examined)*
Aragua 0 / 612
Carabobo 0 / 192
Cojedes 0 / 58
Guarico 0 / 476
Miranda 0 / 478
Yaracuy 0 / 273
Focus 0 / 2,089
* Surveys carried out from 2008 to 2010.evaluation period (Tables 4 and 5). Regarding the upper
confidence interval limits of the prevalence of infective
flies, most of the figures by community and by focus were
under the critical threshold of 1/2,000, except for 5 senti-
nel communities (Tables 4 and 5). However, the upper
limits of the STPs were below the threshold of 20 L3 per
person per season, particularly in the Caituco community
(Table 4), from 2011 onwards. In Table 6 it can be seen
that no Ov-16 IgG4 antibodies were detected in the 3,994
children < 5 years old examined during 2012 from 132
communities within the focus, despite some positive sam-
ples were previously found during 2006 (2/106 children)
and 2009 (1/289 children). Finally, the epidemiological
surveys showed that the prevalence of O. volvulus mf in
the focus (Tables 7 and 8) diminished from a specific
prevalence of 33.3% of mf in skin and a geometric mean
of 0.21 mf per skin snip in the El Piñal community
(CMFL), as an example, to 0 levels during 2012, after 24
rounds of treatment (Table 8). A similar decline was ob-
served with the MFC and MFAC values in this community
by 2012. Three communities (La Carapa, Guayabal and El
Filudo) were the exception within the focus, not showing
mf prevalence < 1% in the skin (Guayabal) or eyes (La
Carapa and El Filudo) during the 2012 survey (Tables 7
and 8). However, when we considered the figures for the
whole focus, either the prevalence of mf in the skin (0.3%;
CMFL = 0.001) or the prevalence in the eyes (MFC =
0.8%; MFAC = 0.2%) were below the critical threshold of
O. volvulus transmission by 2012.
Discussion
Interruption of O. volvulus transmission is defined as
the reduction of parasite infection to such levels (below
specific parasite density breakpoints) that local transmis-
sion can no longer sustain the population [20,31]. This
work has reported the entomological and epidemio-
logical evidences that this disease stage has been reached
in the two Northern foci of Venezuela after 10 (North-
central focus) and 12 (North-east focus) continuous
Table 3 Onchocerca volvulus infection in the human population (sentinel community of Santa Rosa del Sur),
North-central focus, Venezuela
Survey period Prevalence of skin mf (%) Community Microfilariae Load (CMFL) Prevalence of MFC (%) Prevalence of MFAC (%)
2001 2.0 0.01 0.0 0.0
2005 0.0 0.0 1.7 0.0
2008 0.0 0.0 1.8 0.0
2010 0.0 0.0 0.0 0.0
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twice a year to 510 endemic communities in the region.
The first unequivocal signal of current O. volvulus
transmission in an endemic area is the presence of
infective larvae in the head of the vector fly. Here, ento-
mological evaluations carried out in the sentinel and
extra-sentinel communities of both foci showed the
absence of infective-stage (L3) larvae of O. volvulus in
the S. metallicum biting populations suggesting that the
parasite-vector contact has not been taking place in this
endemic area since 2007; this is, after 6 years of con-
secutive human population twice-yearly treatment with
Mectizan® (Tables 1, 4, and 5). Pre-treatment entomo-
logical surveys carried out in the sentinel communities
of the northern endemic area of Venezuela had found
that the S. metallicum infectivity rates varied from
0.0003 (La Carapa) to 0.0009 (La Cuesta) in the North-
east focus, whereas the infectivity rate showed values of
0.0005 in the sentinel locality of the North-central focus
[27]. In our surveys, vector infectivity rates and their
corresponding UL 95% CIs were below 1/2,000 of theTable 4 Seasonal biting density (SBD), prevalence of infective
estimates of S. metallicum (2007–2012) in the sentinel commu
Community Flies collected
La Carapa (2007–2008) 12,014
Voladero (2007–2008) 6,192




La Carapa (2011) 5,642
Voladero (2011) 1,241
Santa Marta (2011) 2,423
Caituco (2011) 4,155
La Cuesta (2011) 3,255
Focus (2011) 16,712
Caituco (2012) 3,923 13,0
ψThe associated 95% Confidence Intervals (CIs) surrounding the point estimate.
γSBD: Mean number (geometric mean) of S. metallicum bites per person per season
δNumber of positive (heads) for O. volvulus L3 per 2 000 flies examined.
θSTP: SBD x prevalence of infective flies x mean number of L3 per infective fly.transmission critical threshold [19,20] in both foci,
except for some communities in the North-east focus.
However, all the seasonal potential transmission values
and their corresponding UL 95% CIs were below 20 L3
per person per season in both foci, including the above
mentioned communities (Tables 1, 4 and 5).
Another strong indicator demonstrating the interrup-
tion of transmission was the absence of antibodies to the
antigen Ov-16 due to recent exposure to O. volvulus in
children up to 5 years of age that had not received treat-
ment [19]. A 5 year cumulative incidence rate with less
than 1 new case per 1,000 susceptible children is accept-
able provided that the appropriate population size is
available. In the North-central focus (Table 2), it was dif-
ficult to find grouped preschool children under the age
of 5 years accessible for sampling because some parents
were reluctant to let very young children submit to
bloodletting. Consequently, we tested 2,089 children up
to 15 years old throughout the 45 endemic communities
which still fulfilled the WHO criteria [20]. By contrast, a
total of 3,994 children up to 5 years old were tested byflies (PIF), and seasonal transmission potential (STP)
nities of the north-east onchocerciasis focus, Venezuela
SBDγ (CI)ψ PIFδ (CI)ψ STPθ (CI)ψ
41,764 0 (0–0.3) 0 (0–6.3)
13,538 0 (0–0.6) 0 (0–4.1)
9,826 0 (0–0.6) 0 (0–2.9)
55,884 0 (0–0.7) 0 (0–19.6)
17,757 0 0
16,362 –19,257) (0–0.1) (0–0.9)
18,528 0 (0–0.7) 0 (0–6.5)
2,907 0 (0–3.1) 0 (0–4.5)
12,799 0 (0–1.6) 0 (0–10.2)
15,511 0 (0–0.9) 0 (0–7.0)
5,617 0 (0–1.2) 0 (0–3.4)
6,199 0 0
(5,717 – 6,719) (0–0.2) (0–0.6)
34 (11,652 – 14,569) 0 (0–1.0) 0 (0–3.4)
.
Table 5 Seasonal biting density (SBD), prevalence of infective flies (PIF), and seasonal transmission potential (STP)
estimates of S. metallicum in the extra-sentinels communities of the North-east onchocerciasis focus, Venezuela, during
2010 and 2012
Community Flies collected SBDγ (CI)ψ PIFδ (CI)ψ STPθ (CI)ψ
Manapire Abajo (2010) 4,208 18,856 0 (1–0.9) 0 (1–8.5)
Guayabal (2010) 9,491 37,007 0 (0–0.4) 0 (0–7.4)
Sabaneta (2010) 4,135 32,764 0 (0–0.2) 0 (0–3.3)
Naranjal (2010) 7,992 31,056 0 (0–0.5) 0 (0–7.8)
El Filudo (2010) 5,144 21,084 0 (0–0.7) 0 (0–7.4)
Focus (2010) 30,970 39,155 0 0
(36,703 – 41,763) (0–0.1) (0–2.0)
Guayabal (2012) 2,411 10,281 (9,612–11,700) 0 (0–1.6) 0 (0–8.2)
Naranjal (2012) 4,321 10,453 (9,256–11,786) 0 (0–0.9) 0 (0–4.7)
ψThe associated 95% Confidence Intervals (CIs) surrounding the point estimate.
γSBD: Mean number (geometric mean) of S. metallicum bites per person per season.
δNumber of positive (heads) for O. volvulus L3 per 2 000 flies examined.
θSTP: SBD x prevalence of infective flies x mean number of L3 per infective fly.
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2012 in the North-east focus (Table 6). In both epi-
demiological settings, we did not detect specific anti-
bodies to O. volvulus, these results imply that no new
infections are occurring in the area. The support for
transmission interruption is even stronger if we use chil-
dren older than 5 years old since acquisition of new
O. volvulus infection rises fastest between 5 and 20 years
of age [20].
Prevalence of < 1% of O. volvulus mf in the cornea
and anterior chamber of the eye as well as < 1% of O.
volvulus mf in the skin were the last WHO criterion
satisfied by our surveys to confirm the interruption of
the parasite in the 6 sentinel communities of both foci.
Overall, all the examined population had < 1 mf for the
skin and eyes by the 2010 (North-central focus) and
2012 (North-east focus) years, respectively, except for 3
communities in the North-east focus. These last results
were accounted for by 3 identified persons (one each
community) who had left the communities and escaped
drug treatment during the last years of MDA; thus, par-
ticular control measures were applied to these persons
at the end of 2012. Currently, our findings stronglyTable 6 Prevalence of IgG4 antibodies to Ov-16 in children
(up to 5 years old) from 132 endemic communities of the
3 administrative States of the North-east focus of
onchocerciasis, Venezuela
State IgG4 prevalence (positive / no.examined)*
Sucre 0 / 2,069
Monagas 0 / 899
Anzoategui 0 / 1,026
Focus 0 (0 – 0.09)γ / 3,994
* Surveys carried out during 2012.
γAssociated 95% Confidence Intervals (CIs).suggest that neither ocular nor skin disease is attribut-
able to O. volvulus infection in the Northern area of
Venezuela.
Since the intensity of transmission and prevalence of
infection in both foci have fallen below accepted thresh-
old values [19,20], this is the first evidence that interrup-
tion of onchocerciasis has been accomplished in the
North endemic area of Venezuela. This means that
around 91% of the population previously at risk in the
country are no longer affected. A total of 20–24 semi-
annual regular treatment rounds with high coverage
(> 85% of the eligible population) have been very import-
ant and effective to reach the goal of interruption of
transmission (Figure 2). Since the human population
represents the only reservoir of human onchocerciasis,
this has been a critical biological factor when consider-
ing control strategies in the Americas [14]. Mectizan®
reduces ≥ 95% of the skin microfilarial load up to 2
months of treatment [15,16], consequently, decreasing
or blocking infection of the black flies [31]. It also has
an embryostatic effect on adult female worms (approxi-
mately 70%), temporarily blocking the release of mf [15]
as well as significantly reducing insemination of females
[16]. Consequently, local elimination of the parasite can
be feasible within this epidemiological period due either
to: i) mono-infections (a single adult male or female
worm) ii) female worms not being fertilised, thus, not
producing microfilariae, or iii) very few microfilariae
being produced and ingested by vector flies in numbers
insufficient to maintain viable annual transmission levels
[31]. Indeed, simulation models (EuSIMON) [33] devel-
oped for both Northern foci after the 10–12 years of
ivermectin treatment predict that local transmission can-
not maintain itself and the adult infection will die out
over time. Reintroduction of the parasite from other
Table 7 Onchocerca volvulus infection in the sentinel communities, North-east focus, Venezuela
Community Survey
period








La Carapa 2001 3.0 0.03 2.3 2.3
2005 3.6 0.03 0.0 0.0
2009 0.7 0.004 0.0 0.8
2012 0.0 0.0 1.0 0.0
Voladero 2001 3.0 0.02 - -
2005 4.0 0.02 - -
2009 2.5 0.01 - -
2012 0.0 0.00 - -
Santa Marta 2001 3.0 0.03 - -
2005 4.2 0.07 - -
2009 0.7 0.01 - -
2012 0.0 0.00 - -
Caituco 2001 15.0 0.12 - -
2005 6.8 0.05 - -
2009 4.8 0.04 - -
2012 0.0 0.00 - -
La Cuesta 2001 3.0 0.01 - -
2005 1.7 0.01 - -
2009 0.7 0.01 - -
2012 0.0 0.01 - -
Table 8 Onchocerca volvulus infection in extra-sentinel communities, North-east focus, Venezuela
Community Survey
period








Manapire Abajo 2006 5.1 0.04 0.7 0.7
2009 0.9 0.01 0.0 0.0
2012 0.0 0.0 0.5 0.0
Guayabal 2006 16.7 0.19 1.3 6.5
2009 12.8 0.16 0.9 1.8
2012 2.0 0.01 0.8 0.0
Filudo 2006 14.9 0.28 0.0 6.5
2009 13.9 0.16 0.0 1.7
2012 0.0 0.0 1.8 1.8
El Piñal 2006 33.3 0.21 0.0 16.7
2009 7.7 0.05 0.0 0.0
2012 0.0 0.0 0.0 0.0
Jenjibral 2006 5.3 0.07 - -
2009 0.0 0.0 - -
2012 0.0 0.0 - -
Apamatal 2006 8.0 0.03 - -
2009 0.0 0.0 - -
2012 0.0 0.0 - -
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http://www.parasitesandvectors.com/content/6/1/289areas is not likely since the disease has been confined to
very small and relatively isolated areas in the northern
mountainous region of the country (Figure 1). On the
other hand, onchocerciasis models and theory predict
that risk of recrudescence will depend on the pre-
control endemicity level and the vector species efficiency
as indicators of the local potential of parasite transmis-
sion [25]. The pre-control endemicity of both foci (the
prevalence and intensity of infection in the human
population) was relatively low compared to the southern
focus of the country [9]. As an example, in the northern
onchocerciasis foci, the community microfilarial load
(CMFL) before mass drug administration never reached
levels above 5 mf per mg of skin in contrast to the
southern focus figures [9]. In addition, S. metallicum has
a relatively low vectorial competence [7] compared to
other Venezuelan and American vector black fly species
[12,31], regardless of its moderate to high biting density
(mean monthly biting rate ranging from 14, 284 to 34,
428 bites per person per month; unpublished results).
WHO certification guidelines for onchocerciasis elimin-
ation recommend that, in areas where transmission has
been interrupted and MDA has been discontinued, post-
treatment surveillance (PTS) should be implemented for 3
years [19,20]. If no recrudescence of infection is detected
during this time, then O. volvulus can be declared to have
been eliminated and the resident population no longer at
risk. Based on these criteria, the Program Coordinating
Committee (PCC) of OEPA recommended to health au-
thorities from the country to stop MDA by 2011 (North-
central focus) and 2013 (North-east focus), respectively.
Following that advice, post-treatment surveillance is cur-
rently ongoing in this northern endemic area of Venezuela.
Our results contribute to the success of the OEPA
strategy [1,4,13,14,34] since the active programs of each
of the other five countries in Latin America have also
made significant progress regarding onchocerciasis
transmission status [4,35-38]. Currently, no new cases of
disease blindness have been reported in the region and
the ocular morbidity has been eliminated from eleven of
the 13 foci. Parasite transmission has been interrupted
in eleven (about 96% of the total population at risk and
representing four of the six countries where the disease
was formerly endemic) with elimination from 7 (33% of
the total at risk) foci. In 2013, onchocerciasis was de-
clared eliminated, for the first time, in Colombia, one of
the 6 endemic countries, whereas by 2014, Ecuador
could become the second Latin American country in
reaching that goal [1]. Indeed, the prospect of eliminat-
ing onchocerciasis from Africa by mass ivermectin alone
has been revived following recent studies in Mali,
Nigeria and Senegal that have indicated that annual (or
biannual) ivermectin distribution may lead to local elim-
ination of onchocerciasis in certain African foci [39-41].Conclusions
We have reported evidences of the local interruption of
O. volvulus transmission by Simulium metallicum in 510 en-
demic communities localized in Northern Venezuela after
10–12 continuous years of 6-monthly ivermectin treatment.
The absence of parasite infective larvae in the black fly vec-
tors, the lack of embryonic parasite forms in the skin and
eyes, and the reduction of exposure to and new infections
with O. volvulus have been the WHO criteria followed to
certify interruption of parasite transmission. Together, the
results presented here also indicate that onchocerciasis in-
fection no longer poses a significant public health risk in
this northern endemic area in Venezuela. Currently, treat-
ment with Mectizan® has been stopped and post-treatment
surveillance is ongoing in the area.
The remaining transmission zone in Venezuela, the
southern onchocerciasis Amazonian focus [9], is the only
active focus in the Americas shared by Brazil [4]. This en-
demic Yanomami area extends through remote and densely
forested zones and is populated by the Yanomami people, a
migratory indigenous group that routinely moves across
the border at will [4,9]. In 2006, the 85% goal of coverage
treatment with ivermectin was reached by the Venezuelan
focus and afterward, in-depth epidemiological evaluations
have shown that infection intensity and infective flies have
decreased by 99%, and eye disease (due to corneal lesions
induced by microfilarial death) by 96% in some sentinel
communities [9]. Since 2009, the Venezuelan program has
introduced the 3-monthly mass treatment in an attempt to
interrupt transmission in this geographical area by 2015
[1,4]. The seminomadic characteristics of the human popu-
lation, the extent and remoteness of the Yanomami area
and the continuing discovery of new endemic communities
on the Venezuelan side are the biggest challenges to face in
promptly interrupting disease transmission throughout the
Amazonian region; however, new approaches and strategies
are being considered to address the issue at country and
international levels.
Competing interests
The authors declare that they all have no competing interests.
Authors’ contributions
HS, VO, MEG, AD and HF designed and performed the data collection and
studies. AD and MEG analyzed the data. MEG wrote the paper. All authors
read and approved the final manuscript.
Acknowledgements
We thank all people from the endemic communities who participated
throughout this work. We are grateful to the logistic support provided by
the personnel of the Minister of Health (Onchocerciasis Elimination Program
of Venezuela), the Biomedicine Institute (IB-MPPS), the Regional Direction of
Sanitary Dermatology (DS-MPPS), the Institute of Superior Studies in Health
(IAE-MPPS), and the Tropical Zoology and Ecology Institute (IZET-UCV). We
also thank the field and laboratory assistance provided by L. Mendez, J. L.
López, A. Bolívar, N. Moncada, Y. Estrada, C. Quinto and F. del Ventura.
Authors acknowledge the laboratory (PCR) and statistical analyses support
given by M. A. Rodriguez-Perez (Centro de Biotecnología Genómica, Instituto
Politécnico Nacional, Reynosa, Mexico), T. Unnasch (University of South
Convit et al. Parasites & Vectors 2013, 6:289 Page 12 of 13
http://www.parasitesandvectors.com/content/6/1/289Florida, Tampa, FL, USA), and D. Rios and A. L. Morales (Onchocerciasis
Elimination Program for the Americas, Guatemala). Nancy Cruz (University of
Valley, Guatemala) performed the serology, whereas H. Margeli-Pérez and R.
Proaño did the ophthalmologist analyses as OEPA´s consultants. We also are
indebted to the Onchocerciasis Elimination Program for the Americas-PCC
(M. Sauerbrey and E. Cupp), Carter Center (F. Richards and Craig Withers),
Centre for Disease Control (Mark Eberhard) and the Panamerican Health
Organization for their valuable technical guidelines and support to the
completion of this work. E. Cupp and two anonymous reviewers made
valuable comments to improve this manuscript.
Funding
This study was supported by the World-Bank, the Venezuelan Minister of
Health, the Biomedicine Institute, the Venezuelan Endemic Diseases Control
Program, the Onchocerciasis Elimination Program for the Americas, the
Carter Center, the Pan-American Health Organization, the United Nations
Development Program, The Bill and Melinda Gates Foundation, and the
Lions Clubs International Foundation. Merck & Co, through the Mectizan
Donation Program (MDP), has donated all the ivermectin through the years.
The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Author details
1Servicio Autónomo Instituto de Biomedicina & Servicio Regionales de
Dermatología Sanitaria, Ministerio del Poder Popular para la Salud, Caracas,
Venezuela. 2Onchocerciasis Elimination Program for the Americas, Guatemala
City, Guatemala. 3Instituto de Altos Estudios “Dr. Arnoldo Gabaldón”,
Ministerio del Poder Popular para la Salud, Maracay, Venezuela. 4Laboratorio
de Biología de Vectores y Parásitos, Instituto de Zoología y Ecología Tropical,
Facultad de Ciencias, Universidad Central de Venezuela, Apartado Postal
47072, Caracas 1041-A, Venezuela.
Received: 7 August 2013 Accepted: 2 October 2013
Published: 7 October 2013
References
1. WER: Progress towards eliminating onchocerciasis in the WHO region of
the Americas: verification by WHO of elimination of transmission in
Colombia. Wkly Epidemiol Rec 2013, 88:381–385.
2. Arends T, Rondon MF, Gonzalez M: Nuevo foco de oncocercosis humana
en Venezuela. Gaceta Med Caracas 1954, 62:645–647.
3. Potenza L, Febres-Cordero R, Anduze PJ: Oncocercosis humana en
Venezuela. Gaceta Med Caracas 1948, 56:219–220.
4. WER: Progress towards eliminating onchocerciasis in the WHO region of the
Americas in 2011: interruption of transmission in Guatemala and Mexico.
Wkly Epidemiol Rec 2012, 87:309–315.
5. Peñalver LM: Estudio de un foco de oncocercosis en la región central de
Venezuela. Determinación de Simulium metallicum y Simulium exiguum
como transmisores de la enfermedad en Venezuela. Rev Venezolana
Sanidad Asistencia Social 1961, 26:898–912.
6. Lewis DJ, Ibáñez de Aldecoa R: Simuliidae and their relation to human
onchocerciasis in northern Venezuela. Bull WHO 1962, 27:449–464.
7. Grillet ME, Botto C, Basáñez MG, Barrera R: Vector competence of Simulium
metallicum s.l. (Diptera: Simuliidae) in two endemic areas of human
onchocerciasis in northern Venezuela. Ann Trop Med Parasitol 1994,
88:65–75.
8. Rassi E, Monzón H, Castillo M, Hernández I, Ramírez-Pérez J, Convit J: Discovery
of a new onchocerciasis focus in Venezuela. Bull Pan Am Health Organ 1977,
11:41–64.
9. Botto C, Villamizar NJ, Jocik Z, Cortés J, Escalona M, Grillet ME, Basáñez MG:
Landscape epidemiology of human onchocerciasis in Southern
Venezuela. In Encyclopedia of Environmental Health, vol. 3. Edited by Nriagu
JO. Burlington: Elsevier; 2011:366–379.
10. Basáñez MG, Yarzábal L, Takaoka H, Suzuki H, Noda S, Tada I: The vectorial
role of several blackfly species (Diptera: Simuliidae) in relation to human
onchocerciasis in the Sierra Parima and Upper Orinoco regions of
Venezuela. Ann Trop Med Parasitol 1988, 82:597–611.
11. Grillet ME, Basáñez MG, Vivas-Martínez S, Villamizar N, Frontado H, Cortez J,
Coronel P, Botto C: Human onchocerciasis in the Amazonian area of southern
Venezuela: spatial and temporal variation in biting and parity rates of black
fly (Diptera: Simuliidae) vectors. J Med Entomol 2001, 38:520–530.12. Grillet ME, Villamizar NJ, Frontado H, Cortez J, Escalona M, Botto C, Basáñez MG:
Vector competence of Simulium oyapockense s.l. and S. incrustatum for
Onchocerca volvulus: Implications for ivermectin-based control in the
Amazonian focus of human onchocerciasis, a multi-vector–host system.
Acta Trop 2008, 107:71–216.
13. Sauerbrey M: The Onchocerciasis Elimination Program for the Americas
(OEPA). Ann Trop Med Parasitol 2008, 102:25–29.
14. Cupp EW, Sauerbrey M, Richards F: Elimination of human onchocerciasis:
history of progress and current feasibility using ivermectin (Mectizan®)
monotherapy. Acta Trop 2011, 120:S100–S108.
15. Duke BOL, Zea-Flores G, Castro J, Cupp EW, Munoz B: Comparison of the effects
of a single dose and four six-monthly doses of ivermectin on adult
Onchocerca volvulus. Am J Trop Med Hyg 1991, 45:132–137.
16. Cupp EW, Duke BOL, Mackenzie CD, Rumbea-Guzman J, Vieira JC,
Mendez-Galvan J, Castro J, Richards F, Sauerbrey M, Dominguez A,
Eversole RR, Cupp MS: The effects of long-term community-level
treatment with ivermectin (Mectizan) on Onchocerca volvulus in Latin
America. Am J Trop Med Hyg 2004, 71:602–607.
17. Cupp EW, Ochoa O, Collins RC, Cupp MS, Gonzales-Peralta C, Castro J, Zea-Flores
G: The effects of repetitive community-wide ivermectin treatment on
transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 1992,
47:170–180.
18. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, Cupp
EW: Ivermectin: Reduction in prevalence and infection intensity with
Onchocerca volvulus, following biannual treatments in five
Guatemalan communities. Am J Trop Med Hyg 1992, 47:156–169.
19. World Health Organization: Guidelines: Certification of Elimination of
Human Onchocerciasis: Criteria and Procedures. Geneva: World Health
Organization; 2001. http://whqlibdoc.who.int/hq/2001/
WHO_CDS_CPE_CEE_2001.18b.
20. PCC: Guide for the detection of a potential recrudescence of
onchocerciasis during the Post Treatment Surveillance (PTS) period: the
American paradigm. Res Rep Trop Med 2011, 3:21–33.
21. Ramírez-Pérez J: Estudio sobre la morfología de Simulium metallicum, vector de la
oncocercosis humana en Venezuela. Washington, D.C.: Organizacion Panamericana
de la Salud (OPS), Publication No. 338; 1977.
22. Katholi CR, Toe L, Merriweather A, Unnasch TR: Determining the
prevalence of Onchocerca volvulus infection in vector populations by
polymerase chain reaction screening of pools of black flies.
J Infect Dis 1995, 172:1414–1417.
23. Unnasch TR, Meredith SEO: The use of degenerate primers in
conjunction with strain and species oligonucleotides to classify
Onchocerca volvulus. In Method in Molecular Biology vol 50. Species
Diagnostics Protocols: PCR and Other Nucleic Acid Methods. Edited by
Clapp JP. Totowa, NJ: Humana Press; 1996:293–303.
24. Lindblade KS, Arana B, Zea-Flores G, Rizzo G, Porter CH, Domínguez A,
Cruz-Ortiz N, Prosser A, Unnasch T, Punkosdy GA, Richards J,
Hengstermann M, Barrios-Giron ME, Sauerbrey M, Castro J, Catú E, Oliva
O, Klein RE, Richards FO Jr: Elimination of Onchocerca volvulus
transmission in the Santa Rosa Focus of Guatemala.
Am J Trop Med Hyg 2007, 77:334–341.
25. Basáñez MG, Collins RC, Porter CH, Little MP, Brandling-Bennett D:
Transmission intensity and the patterns of Onchocerca volvulus infection
in human communities. Am J Trop Med Hyg 2002, 67:669–679.
26. Porter CH, Collins RC, Brandling-Bennett AD: Vector density, parasite prevalence,
and transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg
1988, 39:567–574.
27. Fernández A, Ramírez-Pérez J, Schuler H, Rodríguez N: Reacción en cadena de
polimerasa (PCR) para detectar formas infectivas de Onchocerca volvulus en
Simulium metallicum s.l. (Diptera: Simuliidae) en áreas endémicas de
Venezuela. Bol Malariol Salud 2008, 48:35–43.
28. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB: An
immunogenic Onchocerca volvulus antigen: a specific and early
marker of infection. Science 1991, 251:1603–1605.
29. Weil GJ, Steel C, Liftis F, Li BW, Mearns G, Lobos E, Nutman TB: A
rapid-format antibody card test for diagnosis of onchocerciasis.
J Infect Dis 2000, 182:1796–1799.
30. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, Boatin B,
Weil JG, Nutman TB: Field applicability of a rapid-format anti-Ov-16
antibody test for the assessment of onchocerciasis control measures in
regions of endemicity. J Infect Dis 2006, 194:216–221.
Convit et al. Parasites & Vectors 2013, 6:289 Page 13 of 13
http://www.parasitesandvectors.com/content/6/1/28931. Basáñez MG, Churcher T, Grillet ME: Onchocerca–Simulium interactions and
the population and evolutionary biology of Onchocerca volvulus.
Adv Parasitol 2009, 68:263–313.
32. Katholi CR, Barker J: PoolScreen. Birmingham, AL: University of Alabama at
Birmingham; 2002.
33. Dadzie Y, Neira M, Hopkins D: Final report of the conference on the
eradicability of onchocerciasis. Filarial J 2003, 2:103–105.
34. Gustavsen K, Hopkins A, Sauerbrey M: Onchocerciasis in the Americas,
from arrival to (near) elimination. Parasit Vectors 2011, 4:205.
35. Rodríguez-Pérez MA, Lizarazo-Ortega C, Hassan K, Domínguez-Vásquez A,
Méndez-Galván J, Lugo-Moreno P, Sauerbrey M, Richards F Jr, Unnasch T:
Evidence for suppression of Onchocerca volvulus transmission in the
Oaxaca focus in Mexico. Am J Trop Med Hyg 2008, 78:147–152.
36. Rodríguez-Pérez MA, Unnasch TR, Domínguez-Vázquez A, Morales-Castro
AL, Richards F Jr, Peña-Flores GP, Orozco-Algarra ME, Prado-Velasco G: Lack
of active Onchocerca volvulus transmission in the Northern Chiapas focus
of Mexico. Am J Trop Med Hyg 2010, 83:15–20.
37. Rodríguez-Pérez MA, Domínguez-Vásquez A, Unnasch TR, Hassan HK,
Arredondo-Jimenez JI, Orozco-Algarra ME, Rodríguez-Morales KB, Rodríguez-
Luna IC, Prado-Velasco FG: Interruption of transmission of Onchocerca
volvulus in the Southern Chiapas focus, Mexico. PLoS Negl Trop Dis 2013,
7:e2133.
38. Gonzalez RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A,
Sauerbrey M, Catú E, Oliva O, Richards FO, Lindblade KA: Successful
interruption of transmission of Onchocerca volvulus in the Escuintla-
Guatemala focus, Guatemala. PLoS Negl Trop Dis 2009, 3:e404.
39. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konaté L,
Mounkoro K, Sarr MD, Seck AF, Toé L, Tourée S, Remme JHF: Feasibility of
Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci
in Africa: First Evidence from Studies in Mali and Senegal. PLoS Negl Trop
Dis 2009, 3:e497.
40. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, Goita SF,
Konnate L, Mounkoro K, Seck AF, Toe L, Toure S, Remme JHF: Proof-of-
Principle of Onchocerciasis Elimination with Ivermectin Treatment in
Endemic Foci in Africa: Final Results of a Study in Mali and Senegal.
PLoS Negl Trop Dis 2012, 6:e1825.
41. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S,
Abiose A, Remme JH: Impact of long-term treatment of onchocerciasis
with ivermectin in Kaduna State, Nigeria: first evidence of the potential
for elimination in the operational area of the African Programme for
Onchocerciasis Control. Parasit Vectors 2012, 5:28.
doi:10.1186/1756-3305-6-289
Cite this article as: Convit et al.: Interruption of Onchocerca volvulus
transmission in Northern Venezuela. Parasites & Vectors 2013 6:289.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
